ROHM CO LTD/ADR (OTCMKTS:ROHCY) Shares Up 3.5%

Share on StockTwits

ROHM CO LTD/ADR (OTCMKTS:ROHCY) shares shot up 3.5% during trading on Tuesday . The stock traded as high as $39.59 and last traded at $39.59, 206 shares were traded during trading. A decline of 71% from the average session volume of 702 shares. The stock had previously closed at $38.26.

The stock has a market capitalization of $8.11 billion, a price-to-earnings ratio of 18.22 and a beta of 1.09. The company has a 50 day moving average of $36.22 and a 200 day moving average of $33.83.

ROHM CO LTD/ADR Company Profile (OTCMKTS:ROHCY)

ROHM Co, Ltd. manufactures and sells electronic components in Japan, the Americas, Europe, Asia, and internationally. It operates through LSI, Discrete Semiconductor Devices, Modules, and Others segments. The company offers ICs, including memory, amplifier and linear, power management, clocks and timers, switches and multiplexers, logic, data converter, sensor and MEMS, digital power, display driver, motor/actuator driver, interface, communication and speech synthesis LSI, audio and video, microcontroller, analog, logic, and memory ICs.

Further Reading: What does a market perform rating mean?

Receive News & Ratings for ROHM CO LTD/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ROHM CO LTD/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

National Bank Financial Equities Analysts Cut Earnings Estimates for Sleep Country Canada Holdings Inc
National Bank Financial Equities Analysts Cut Earnings Estimates for Sleep Country Canada Holdings Inc
Watsco Inc  to Post FY2019 Earnings of $6.40 Per Share, Jefferies Financial Group Forecasts
Watsco Inc to Post FY2019 Earnings of $6.40 Per Share, Jefferies Financial Group Forecasts
Research Analysts Offer Predictions for Union Pacific Co.’s FY2019 Earnings
Research Analysts Offer Predictions for Union Pacific Co.’s FY2019 Earnings
Q3 2019 Earnings Estimate for Aquestive Therapeutics Inc Issued By Wedbush
Q3 2019 Earnings Estimate for Aquestive Therapeutics Inc Issued By Wedbush
Homology Medicines  Upgraded to Buy at ValuEngine
Homology Medicines Upgraded to Buy at ValuEngine
Rand Capital  Cut to “Sell” at ValuEngine
Rand Capital Cut to “Sell” at ValuEngine


 
© 2006-2019 Zolmax.